Pangali EV/EBITDA Avantor, Inc. (AVTR)

Avantor, Inc. (AVTR) is betting on the robotic production of sterile chemicals within closed systems. Supply diversification for biopharmaceuticals and education protects the company from industry crises, while capacity modernization ensures a stable cycle. The EV/EBITDA ratio demonstrates the business's debt resilience, with 14.51 representing the current metric value.

Investors use this ratio to determine the fair value of a business while accounting for its debt load. The metric relates total equity and net debt to operating profit before depreciation and amortization. By analyzing the EV/EBITDA multiple of Avantor, Inc. (AVTR) over time, one can track the market's revaluation of the asset's risks. The high valuation of Avantor, Inc. (AVTR) is justified by its exclusive right to produce ultra-pure materials and strict compliance with FDA standards.